2-(2,4-Dichloroanilino)benzo[f][1,3]benzothiazole-4,9-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 萘并噻唑类
• 英文名称: 2-(2,4-Dichloroanilino)benzo[f][1,3]benzothiazole-4,9-dione
• 化学式: C₁₇H₈Cl₂N₂O₂S
• 分子量: 375.2
• InChiKey: JASHLKNQHQDYAW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  87.3
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• METHODS OF MANAGING BLOOD SUGAR LEVELS AND COMPOSITIONS RELATED THERETO
  申请人：Ye Keqiang

  公开号：US20130158082A1

  公开（公告）日：2013-06-20

  The disclosure relates to methods of managing blood sugar levels and compositions related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diabetes, insulin resistance, or hyperglycemia comprising administering to a subject diagnosed with, at risk of or exhibiting symptoms of diabetes, insulin resistance, or hyperglycemia a pharmaceutical composition comprising a compound comprising formula I.

  本公开涉及管理血糖水平的方法及相关组合物。在某些实施例中，本公开涉及治疗或预防糖尿病、胰岛素抵抗或高血糖的方法，包括向被诊断为、处于风险中或表现出糖尿病、胰岛素抵抗或高血糖症状的受试者施用含有式I化合物的制药组合物。
• US9040713B2
  申请人：——

  公开号：US9040713B2

  公开（公告）日：2015-05-26
• [EN] METHODS OF MANAGING BLOOD SUGAR LEVELS AND COMPOSITIONS RELATED THERETO<br/>[FR] PROCÉDÉS DE CONTRÔLE DES TAUX DE SUCRE DANS LE SANG ET COMPOSITIONS ASSOCIÉES À CEUX-CI
  申请人：UNIV EMORY

  公开号：WO2012047628A2

  公开（公告）日：2012-04-12

  The disclosure relates to methods of managing blood sugar levels and compositions related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diabetes, insulin resistance, or hyperglycemia comprising administering to a subject diagnosed with, at risk of, or exhibiting symptoms of diabetes, insulin resistance, or hyperglycemia a pharmaceutical composition comprising a compound comprising formula I.